HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rx-to-OTC Switch

Set Alert for Rx-To-OTC Switch

Five Must-Know Things About The UK’s Digital Self-Care Revolution

HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

United Kingdom Health

Switzerland Reclassifies Rx Drugs For Migraine And Pain

Switzerland has added treatments for migraine and acute pain to the list of Rx drugs permitted for sale without prescription in pharmacy.

Switzerland Regulation

Clean Sweep For German Rx-To-OTC Switches Of Next-Gen Pain And Cough Treatments

Germany’s Expert Committee for Prescription has recommended three novel Rx-to-OTC switch applications: analgesics dexibuprofen and ibuprofen/paracetamol single-pill combinations, and cough treatment levodropropizine.

Germany Health

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 

United Kingdom Health

In OTC Tests, Naloxone Absorption Slowed When Administered After Subjects Had Used Masks

Testing results for subjects who wore face masks before and after intranasal administration suggest early absorption of naloxone was adversely affected. Expanding Access to Affordable Prescription Drugs and Medical Devices Act would provide support for nonprofits such as Harm Reduction Therapeutics, which continues research for an NDA for an OTC naloxone nasal spray.

FDA Legislation

Over The Counter, 28 June 2021: The Promise Of Digital Health, with PAGB's Michelle Riddalls

In this bonus edition of HBW Insight's new 'Over The Counter' podcast, David Ridley (Senior Editor, EU), speaks to the PAGB's Michelle Riddalls about the association's upcoming Digital Week event (5-9 July) and the promise of digitalization for the UK consumer healthcare industry. 

United Kingdom Health

Market Exclusivity Decision Pending For Bayer’s First-In-Class OTC Switch Astepro Allergy

Astepro Allergy’s attributes include being the first steroid-free, antihistamine nasal spray for allergies available OTC in the US and the first indicated for indoor and outdoor allergy relief. An attribute yet to be determined will have most influence on revenue boost for Bayer: three-year market exclusivity.

FDA Prescription To Otc Switch

Progress On Adding OTC Drugs To US Market? Room To Move But Label Format Limits Options

Changes for supporting OTC labeling for drugs currently available Rx-only and indicated for chronic, more complicated conditions, aren’t minor and won’t happen within limits of one-dimensional text media printed on OTC drug containers, packages and inserts.

See All